Author

Joshua Yueh

Icahn School of Medicine at Mount Sinai

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Organism:human· 1 Assay:metagenomics· 1 Organism:mouse· 1

Frequent Co-Authors

Disha BhavsariD· 2 shared Eduard Puente‐MassagueriD· 2 shared Florian KrammeriD· 2 shared Kirill VasileviD· 2 shared Alesandra J. RodrigueziD· 1 shared Andrew B. WardiD· 1 shared Corey P. MallettiD· 1 shared Dong Yu· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Disha BhavsarORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A clade 2.3.4.4b H5N1 virus vaccine that elicits cross-protective antibodies against conserved domains of H5 and N1 glycoproteins

Eduard Puente‐Massaguer, Thales Galdino Andrade, Michael J. Scherm, Kirill Vasilev, Hassanein H. Abozeid, Alesandra J. Rodriguez, Joshua Yueh, Disha Bhavsar, John D. Campbell, Dong Yu, Richard J. Webby, Yoshihiro Kawaoka, Gabriele Neumann, Julianna Han, Andrew B. Ward, Florian Krammer

This paper evaluates a low-dose inactivated split virus vaccine against H5N1 influenza, showing cross-protective immunity against multiple clades in a mouse model.

Nature Communications · Jan 23, 2026Peer-reviewedMicrobiology

Immunogenicity and protective efficacy of an intranasal neuraminidase-based influenza virus vaccine adjuvanted with bacterial cell membrane-derived adjuvants

Kirill Vasilev, Irene Hoxie, Eduard Puente‐Massaguer, Joshua Yueh, Disha Bhavsar, Maya Singh, Corey P. Mallett, Joseph Zimmermann, Florian Krammer

This study evaluates an intranasal influenza vaccine based on neuraminidase (NA) adjuvanted with bacterial membrane-derived components, showing improved immunogenicity and protection against H5N1 challenge.

bioRxiv · Feb 26, 2025 · PreprintMicrobiology